Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Operating Leases (2020 - 2026)

Palatin Technologies' (PTN) quarterly Operating Leases came in at $97457.0 in Q1 2026, up 44.92% on a YoY basis from $67248.0 in Q1 2025, and down 24.49% quarter-over-quarter from $129061.0 in Q4 2025.

Analysis

Palatin Technologies (PTN) Operating Leases (2020 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Operating Leases for 7 consecutive years, with $97457.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases rose 44.92% year-over-year to $97457.0; the trailing twelve-month figure through Mar 2026 stood at $97457.0 (up 44.92% YoY), and the FY2025 full-year result was $33969.0, down 79.26% from the prior year.
  • Operating Leases slipped to $97457.0 in Q1 2026 per PTN's latest filing, from $129061.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $621660.0 in Q1 2022 and bottomed at $33969.0 in Q2 2025.
  • Historically, Operating Leases has averaged $292885.5 across 5 years, with a median of $291355.0 in 2023.
  • The sharpest annual moves came in 2025 and 2026: Operating Leases slumped 79.26% in 2025, then jumped 44.92% in 2026.
  • Over 5 years, Operating Leases stood at $380161.0 in 2022, then slipped by 5.9% to $357744.0 in 2023, then sank by 72.03% to $100071.0 in 2024, then increased by 28.97% to $129061.0 in 2025, then decreased by 24.49% to $97457.0 in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $97457.0, $129061.0, and $33969.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 97,457.00
Dec 31, 2025 129,061.00
Jun 30, 2025 33,969.00
Mar 31, 2025 67,248.00
Dec 31, 2024 100,071.00
Sep 30, 2024 132,447.00
Jun 30, 2024 163,782.00
Mar 31, 2024 262,220.00
Dec 31, 2023 357,744.00
Sep 30, 2023 481,046.00
Jun 30, 2023 544,323.00
Mar 31, 2023 320,490.00
Dec 31, 2022 380,161.00
Sep 30, 2022 465,091.00
Jun 30, 2022 529,398.00
Mar 31, 2022 621,660.00
Dec 31, 2021 715,893.00
Sep 30, 2021 808,840.00
Jun 30, 2021 900,520.00
Mar 31, 2021 986,175.00